[Treatment of cerebral infarction in the acute stage with synthetic antithrombin MD-805: a multicenter clinical study].
D000991:Antithrombins / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D002544:Cerebral Infarction / Q000188:drug therapy*; D004341:Drug Evaluation; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D010875:Pipecolic Acids / Q000627:therapeutic use*; D013449:Sulfonamides
D000991:Antithrombins; D010875:Pipecolic Acids; D013449:Sulfonamides; D001120:Arginine; C031942:argatroban